面对美国政府日益加剧的药价管控压力,瑞士制药巨头罗氏(Roche)提出了一项可能重塑行业格局的方案,其首席执行官直言,若能绕开中间环节直接向患者销售药品,美国药价可“非常容易地”削减一半。 据《金融时报》7月24日报道,罗氏首席执行官Thomas Schinecker透露,公司正与美国政府就此方案进行商谈。他指出,当前的药品供应链中,被称为“药品福利管理者”(PBMs)的中间商攫取了高达一半的收益...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.